SPEAKERS

Ros Quinlivan, Professor of Neuromuscular Diseases (NMD) at the Queen Square Centre for Neuromuscular Disease in London, originally trained in Paediatrics but after completing her research degree on the cardiomyopathy of Duchenne and Becker muscular dystrophy, developed an interest in both adult and paediatric NMD. She developed the Neuromuscular Complex Care Centre (NMCCC) which co-ordinates all aspects of neuromuscular care in one in-patient episode. She leads for transition and manages a large cohort of young adults with childhood onset NMD including DMD and she runs a national diagnostic and management service for McArdle disease and related disorders.

She leads the Adult North Star Network which developed UK standards of care for adults with DMD. She has been PI for clinical trials in DMD, SMA, myotubular myopathy, Becker MD and McArdle disease. Previously, she was co-ordinating editor for Cochrane Neuromuscular and chair of the British Myology Society. She is currently research director for the European Neuromuscular Centre (ENMC).

Dr. Liewluck is a Professor of Neurology at the Mayo Clinic College of Medicine in Rochester, Minnesota, USA. He is board certified in Neurology, Neuromuscular Medicine, and Clinical Neuromuscular Pathology. His clinical practice and research focus on muscle diseases, with particular expertise in (1) autoimmune myositis; (2) immune checkpoint inhibitor–associated myopathy; (3) monoclonal gammopathy–associated myopathies; (4) critical illness myopathy; (5) rhabdomyolysis; and (6) hereditary and acquired lipid storage myopathies.

Dr. Liewluck has authored over 145 peer-reviewed articles and nine book chapters and has co-edited one book. He is actively involved in professional organizations, including the World Muscle Society (WMS), American Academy of Neurology (AAN), American Neurological Association (ANA), American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM), International Myositis Assessment and Clinical Studies Group (IMACS), International Myositis Society (IMyoS), and the United Council for Neurologic Subspecialties (UCNS). 

He served as Chair of the ANA Neuromuscular Disease Special Interest Group in 2023, Vice Chair of the AAN Neuromuscular Section from 2023 to 2025, and Vice Chair of the IMACS Scientific Committee from 2023 to 2025. He currently chairs the AANEM Abstract Review Committee, is an Associate Board Member of IMyoS, and serves on the UCNS Clinical Neuromuscular Pathology Examination Committee.